Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
48
STT Quote, Financials, Valuation and Earnings
Last price:
$98.24
Seasonality move
:
7.04%
Day range:
$94.83 - $98.63
52-week range:
$70.20 - $101.91
Dividend yield:
2.88%
P/E ratio:
15.51x
P/S ratio:
2.39x
P/B ratio:
1.25x
Volume:
6.1M
Avg. volume:
2.3M
1-year change:
29.13%
Market cap:
$28.8B
Revenue:
$11.9B
EPS (TTM):
$6.33
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $11.8B | $11.7B | $12B | $12.1B | $11.9B | |
| Revenue Growth (YoY) | -3.09% | -0.53% | 2.85% | 0.82% | -1.49% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.6B | $4.4B | $4.7B | $4.5B | $4.7B | |
| Other Inc / (Exp) | -$1M | $4M | $57M | -$2M | -$294M | |
| Operating Expenses | $4.5B | $4.5B | $4.8B | $4.6B | $4.3B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.7B | $2.9B | $3.2B | $3.3B | $2.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $470M | $479M | $478M | $553M | $372M | |
| Net Income to Company | $2.2B | $2.4B | $2.7B | $2.8B | $1.9B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.2B | $2.4B | $2.7B | $2.8B | $1.9B | |
| Basic EPS (Cont. Ops) | $5.43 | $6.40 | $7.30 | $7.28 | $5.65 | |
| Diluted EPS (Cont. Ops) | $5.38 | $6.32 | $7.19 | $7.19 | $5.58 | |
| Weighted Average Basic Share | $369.9M | $352.9M | $352.6M | $365.2M | $322.3M | |
| Weighted Average Diluted Share | $373.7M | $357.1M | $358M | $370.1M | $326.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $4.1B | $3.3B | $3.2B | $4.9B | $8.7B | |
| Revenue (Reported) | $11.8B | $11.7B | $12B | $12.1B | $11.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $4.1B | $3.3B | $3.2B | $4.9B | $8.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.8B | $3B | $3B | $2.7B | $3.2B | |
| Revenue Growth (YoY) | -4.1% | 7.4% | -1.04% | -9.06% | 18.1% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.1B | $1.1B | $1.1B | $1.1B | $1.2B | |
| Other Inc / (Exp) | -- | -$1M | -- | -$294M | -$14M | |
| Operating Expenses | $1.1B | $1.1B | $1.1B | $1.2B | $1.3B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $681M | $876M | $849M | $511M | $925M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $126M | $162M | $159M | $89M | $195M | |
| Net Income to Company | $555M | $714M | $690M | $422M | $730M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $555M | $714M | $690M | $422M | $730M | |
| Basic EPS (Cont. Ops) | $1.47 | $1.99 | $1.82 | $1.27 | $2.29 | |
| Diluted EPS (Cont. Ops) | $1.45 | $1.96 | $1.80 | $1.25 | $2.26 | |
| Weighted Average Basic Share | $352.6M | $347.7M | $367.8M | $313.1M | $297.4M | |
| Weighted Average Diluted Share | $357.2M | $353.5M | $372.4M | $317.3M | $301.8M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $723M | $876M | $1.3B | $2.2B | $3.3B | |
| Revenue (Reported) | $2.8B | $3B | $3B | $2.7B | $3.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $723M | $876M | $1.3B | $2.2B | $3.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $11.8B | $11.8B | $12B | $12B | $12.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.5B | $4.5B | $4.6B | $4.7B | $4.7B | |
| Other Inc / (Exp) | $1M | $54M | $56M | -$294M | -$14M | |
| Operating Expenses | $4.3B | $4.6B | $4.8B | $4.8B | $4.9B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.9B | $3.1B | $3.2B | $3B | $2.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $449M | $549M | $430M | $537M | $522M | |
| Net Income to Company | $2.4B | $2.5B | $2.7B | $2.5B | $2.1B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $2.4B | $2.5B | $2.7B | $2.5B | $2.1B | |
| Basic EPS (Cont. Ops) | $6.74 | $6.90 | $7.16 | $6.95 | $6.41 | |
| Diluted EPS (Cont. Ops) | $6.66 | $6.79 | $7.06 | $6.85 | $6.33 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.5B | $3.1B | $3.7B | $8.5B | $11.3B | |
| Revenue (Reported) | $11.8B | $11.8B | $12B | $12B | $12.6B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.5B | $3.1B | $3.7B | $8.5B | $11.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $8.8B | $8.9B | $9B | $8.9B | $9.5B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $3.4B | $3.4B | $3.4B | $3.6B | $3.6B | |
| Other Inc / (Exp) | $2M | $52M | -$2M | -$294M | -$14M | |
| Operating Expenses | $3.5B | $3.6B | $3.5B | $3.8B | $3.7B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.3B | $2.4B | $2.4B | $2.1B | $2.4B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $375M | $445M | $397M | $381M | $531M | |
| Net Income to Company | $1.9B | $2B | $2B | $1.7B | $1.9B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.9B | $2B | $2B | $1.7B | $1.9B | |
| Basic EPS (Cont. Ops) | $4.99 | $5.49 | $5.35 | $5.01 | $5.85 | |
| Diluted EPS (Cont. Ops) | $4.93 | $5.40 | $5.28 | $4.94 | $5.78 | |
| Weighted Average Basic Share | $1.1B | $1B | $1.1B | $983.6M | $899.9M | |
| Weighted Average Diluted Share | $1.1B | $1.1B | $1.1B | $996.3M | $912.6M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.6B | $2.4B | $3B | $6.6B | $9.2B | |
| Revenue (Reported) | $8.8B | $8.9B | $9B | $8.9B | $9.5B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.6B | $2.4B | $3B | $6.6B | $9.2B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $72.3B | $120.5B | $110.1B | $105.6B | $91.8B | |
| Short Term Investments | $53.8B | $59B | $73.4B | $40.6B | $12.7B | |
| Accounts Receivable, Net | $3.7B | $3.5B | $3.5B | $3.8B | $4.4B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $395M | $843M | $1.2B | $558M | $598M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $137.1B | $193.3B | $195.8B | $164.1B | $122.9B | |
| Property Plant And Equipment | $3.1B | $2.9B | $2.8B | $2.8B | $3.2B | |
| Long-Term Investments | $99.4B | $115.2B | $119.7B | $109.2B | $105.4B | |
| Goodwill | $7.6B | $7.7B | $7.6B | $7.5B | $7.6B | |
| Other Intangibles | $2B | $1.8B | $1.8B | $1.5B | $1.3B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $245.6B | $314.7B | $314.6B | $301.5B | $297.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $839M | $4B | $128M | $2.1B | $2.7B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.9B | $7.4B | $4.2B | $5.4B | $8.7B | |
| Long-Term Debt | $12.4B | $13.7B | $10.8B | $12.7B | $15.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $221.2B | $288.5B | $287.3B | $276.3B | $273.5B | |
| Common Stock | $3.5B | $3B | $2.5B | $2.5B | $2.5B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $21.5B | $23.7B | $25.4B | $23.2B | $21.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $24.4B | $26.2B | $27.4B | $25.2B | $23.8B | |
| Total Liabilities and Equity | $245.6B | $314.7B | $314.6B | $301.5B | $297.3B | |
| Cash and Short Terms | $126.1B | $179.5B | $183.5B | $146.2B | $104.5B | |
| Total Debt | $13.2B | $17.7B | $13.4B | $16.9B | $21.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $80.9B | $112.2B | $102B | $80.8B | $109.3B | |
| Short Term Investments | $8.6B | $13.7B | $8.3B | $16.2B | $14.3B | |
| Accounts Receivable, Net | $3.7B | $3.8B | $3.9B | $4.3B | $4.7B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $411M | $474M | $1.4B | $610M | $839M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $104.4B | $141.6B | $129.3B | $112.5B | $142.6B | |
| Property Plant And Equipment | $3B | $2.8B | $2.8B | $3.2B | $3.5B | |
| Long-Term Investments | $116B | $117.5B | $110.2B | $107.1B | $110.3B | |
| Goodwill | $7.6B | $7.7B | $7.4B | $7.5B | $7.8B | |
| Other Intangibles | $1.9B | $1.9B | $1.6B | $1.4B | $1.2B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $272.1B | $323.1B | $303.6B | $284.4B | $338.5B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $10.7B | $549M | $109M | $8M | $10B | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $13.1B | $1.2B | $4.4B | $3.1B | $12.1B | |
| Long-Term Debt | $13.9B | $13B | $14B | $18.6B | $20.9B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $246.5B | $295.8B | $277.9B | $260.8B | $312.7B | |
| Common Stock | $3B | $2.5B | $2.5B | $2.5B | $3.3B | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | $342M | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $25.6B | $27.3B | $25.6B | $23.6B | $25.8B | |
| Total Liabilities and Equity | $272.1B | $323.1B | $303.6B | $284.4B | $338.5B | |
| Cash and Short Terms | $89.5B | $125.9B | $110.3B | $97B | $123.5B | |
| Total Debt | $24.5B | $13.5B | $14.1B | $18.6B | $30.9B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.2B | $2.4B | $2.7B | $2.8B | $1.9B | |
| Depreciation & Amoritzation | $1.3B | $1.5B | $1.6B | $1.2B | $882M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$28M | $127M | -$173M | -$156M | -$359M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $5.7B | $3.5B | -$6.7B | $12B | $690M | |
| Capital Expenditures | $730M | $560M | $811M | $734M | $816M | |
| Cash Acquisitions | -$54M | -- | -$333M | -- | -$61M | |
| Cash From Investing | -$2.6B | -$65.5B | -$2.2B | $6.8B | $12.7B | |
| Dividends Paid (Ex Special Dividend) | -$930M | -$889M | -$866M | -$972M | -$970M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.5B | $5.8B | $1.3B | $5.7B | $6.8B | |
| Long-Term Debt Repaid | -$2.7B | -$1.9B | -$5.3B | -$1.6B | -$2.5B | |
| Repurchase of Common Stock | -$2.4B | -$1.1B | -$1.4B | -$1.6B | -$3.9B | |
| Other Financing Activities | -- | -- | -- | -- | $57M | |
| Cash From Financing | -$3B | $62.2B | $9B | -$18.4B | -$13.4B | |
| Beginning Cash (CF) | $3.2B | $3.3B | $3.5B | $3.6B | $4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $90M | $165M | $164M | $339M | $77M | |
| Ending Cash (CF) | $3.3B | $3.5B | $3.6B | $4B | $4B | |
| Levered Free Cash Flow | $5B | $3B | -$7.5B | $11.2B | -$126M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $555M | $714M | $690M | $422M | $730M | |
| Depreciation & Amoritzation | -$1.3B | $377M | $196M | $223M | $144M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$57M | -$48M | -$123M | -$142M | -$95M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$5.2B | $388M | $4.5B | $222M | $2.7B | |
| Capital Expenditures | $153M | $197M | $210M | $135M | $234M | |
| Cash Acquisitions | -- | -$89M | -- | -- | -- | |
| Cash From Investing | $12.2B | $2.6B | -$5.3B | $10.2B | -$6.3B | |
| Dividends Paid (Ex Special Dividend) | -$221M | -$199M | -$230M | -$227M | -$249M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $746M | $1.5B | $996M | |
| Long-Term Debt Repaid | -$8M | -$8M | $20M | -$13M | -$11M | |
| Repurchase of Common Stock | -$14M | -- | -$96M | -$1B | -$963M | |
| Other Financing Activities | -- | -- | -- | -- | -$4M | |
| Cash From Financing | -$5.8B | -$3B | $101M | -$10.3B | $4.7B | |
| Beginning Cash (CF) | $3.7B | $4.6B | $3.5B | $3.9B | $2.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.2B | -$13M | -$767M | $79M | $1.2B | |
| Ending Cash (CF) | $4.8B | $4.6B | $2.7B | $4B | $4.1B | |
| Levered Free Cash Flow | -$5.4B | $191M | $4.3B | $87M | $2.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.4B | $2.5B | $2.7B | $2.5B | $2.1B | |
| Depreciation & Amoritzation | -$255M | $3.3B | $1.1B | $1.1B | $677M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$33M | -$115M | -$119M | -$348M | -$270M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.2B | -$7.6B | $9.1B | $3.5B | -$1.6B | |
| Capital Expenditures | $585M | $692M | $785M | $691M | $1B | |
| Cash Acquisitions | -- | -$333M | -- | -- | -$255M | |
| Cash From Investing | -$31.6B | -$39.9B | $6.2B | $25.5B | -$42.3B | |
| Dividends Paid (Ex Special Dividend) | -$905M | -$846M | -$947M | -$987M | -$1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -$237M | $4.1B | $3.2B | $7.7B | $4B | |
| Long-Term Debt Repaid | -$2.6B | -$3.4B | -$5.3B | -$1.1B | -$1.5B | |
| Repurchase of Common Stock | -$2.3B | -$1.4B | -$129M | -$4.9B | -$2.8B | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $31.7B | $47.2B | -$17.2B | -$27.8B | $43.9B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.3B | -$242M | -$1.9B | $1.3B | $58M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $624M | -$8.3B | $8.4B | $2.9B | -$2.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.9B | $2B | $2B | $1.7B | $1.9B | |
| Depreciation & Amoritzation | -$618M | $1.2B | $737M | $691M | $486M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -$60M | -$302M | -$248M | -$440M | -$351M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $156M | -$10.9B | $4.9B | -$3.5B | -$5.8B | |
| Capital Expenditures | $424M | $556M | $530M | $487M | $677M | |
| Cash Acquisitions | -- | -$333M | -- | -- | -$194M | |
| Cash From Investing | -$26.1B | -$478M | $7.9B | $26.6B | -$28.4B | |
| Dividends Paid (Ex Special Dividend) | -$666M | -$623M | -$704M | -$719M | -$755M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.5B | $844M | $2.7B | $4.7B | $2B | |
| Long-Term Debt Repaid | -$24M | -$1.5B | -$1.5B | -$1B | -$35M | |
| Repurchase of Common Stock | -$1.1B | -$1.4B | -$96M | -$3.4B | -$2.3B | |
| Other Financing Activities | -- | -- | -- | -- | -$16M | |
| Cash From Financing | $27.5B | $12.6B | -$13.7B | -$23B | $34.2B | |
| Beginning Cash (CF) | $11.9B | $12.6B | $10.1B | $11.6B | $10.4B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.5B | $1.1B | -$883M | $39M | $20M | |
| Ending Cash (CF) | $13.5B | $13.8B | $9.2B | $11.6B | $10.4B | |
| Levered Free Cash Flow | -$268M | -$11.5B | $4.4B | -$4B | -$6.5B | |
Get STT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
STT
Sector
P/E ratio
15.51x
11.99x
PEG ratio
--
0.36x
P/B ratio
1.25x
1.05x
Price / LTM sales
2.39x
2.55x
Growth Metrics
STT
Sector
Revenue growth
18.1%
6.08%
Earnings growth
80.8%
6.45%
Revenue (5-year growth)
-0.31%
5.85%
Earnings forecast
$2.12
$0.56
Profitability
STT
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
4.1%
5.27%
Return on assets
0.67%
0.98%
Return on equity
8.63%
9.43%
Earnings Date
Last Earnings Date
Oct
15
Next Earnings Date
Jan
17
Estimated Next Earnings Date
Jan
14
Balance Sheet
STT
Sector
Total cash
$123.5B
$615.3M
Short term investments
$12.7B
$408.4M
Total assets
$297.3B
$4.5B
Long term debt
$30.9B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
